Cerebral blood flow laterality derived from arterial spin labeling as a biomarker for assessing the disease severity of parkinson's disease.

MLA

Yamashita, Koji, et al. “Cerebral Blood Flow Laterality Derived from Arterial Spin Labeling as a Biomarker for Assessing the Disease Severity of Parkinson’s Disease.” Journal of Magnetic Resonance Imaging : JMRI, vol. 45, no. 6, June 2017, pp. 1821–26. EBSCOhost, https://doi.org/10.1002/jmri.25489.

APA

Yamashita, K., Hiwatashi, A., Togao, O., Kikuchi, K., Yamaguchi, H., Suzuki, Y., Kamei, R., Yamasaki, R., Kira, J.-I., & Honda, H. (2017). Cerebral blood flow laterality derived from arterial spin labeling as a biomarker for assessing the disease severity of parkinson’s disease. Journal of Magnetic Resonance Imaging : JMRI, 45(6), 1821–1826. https://doi.org/10.1002/jmri.25489

Chicago

Yamashita, Koji, Akio Hiwatashi, Osamu Togao, Kazufumi Kikuchi, Hiroo Yamaguchi, Yuriko Suzuki, Ryotaro Kamei, Ryo Yamasaki, Jun-Ichi Kira, and Hiroshi Honda. 2017. “Cerebral Blood Flow Laterality Derived from Arterial Spin Labeling as a Biomarker for Assessing the Disease Severity of Parkinson’s Disease.” Journal of Magnetic Resonance Imaging : JMRI 45 (6): 1821–26. doi:10.1002/jmri.25489.